ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CRISPR enzyme can also cleave RNA, finds study – News-Medical.net

News-Medical.netCRISPR enzyme can also cleave RNA, finds studyNews-Medical.netCRISPR utilizes the immune system of bacteria, which incorporates short lengths of DNA from invading viruses into its own genome. These sequences provide a template for recog… Continue reading

2018-03-02 Michael Zand NEWS

MeiraGTx Receives EMA PRIME Designation for Achromatopsia Gene Therapy Candidate – Business Wire (press release)

Continue reading

2018-03-02 Michael Zand NEWS

7 Steps to Better Gene Editing and CRISPR technology – Special Feature – SelectScience

SelectScience7 Steps to Better Gene Editing and CRISPR technology – Special FeatureSelectScienceIn this editorial feature, we bring you the latest developments in gene editing and CRISPR technology. 02 Mar 2018. Gene editing and CRISPR special feature… Continue reading

2018-03-02 Michael Zand NEWS

Editorial Article: 7 Steps to Better Gene Editing and CRISPR – Special Feature – SelectScience

SelectScienceEditorial Article: 7 Steps to Better Gene Editing and CRISPR – Special FeatureSelectScienceIn this editorial feature, we bring you the latest developments in gene editing and CRISPR technology. 02 Mar 2018. AddThis Sharing Buttons. Share t… Continue reading

2018-03-02 Michael Zand NEWS

Editorial Article: 7 Steps to Better Gene Editing and CRISPR technology – Special Feature – SelectScience


Business Wire (press release)

MeiraGTx Receives EMA PRIME Designation for Achromatopsia Gene Therapy Candidate
Business Wire (press release)
LONDON & NEW YORK–(BUSINESS WIRE)–MeiraGTx, a London and New York based gene therapy company, announced today the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to MeiraGTx’s gene therapy product candidate A002 for …

and more »

Continue reading

2018-03-02 Michael Zand NEWS

Dr. Skarbnik on Combination Strategies of Immunotherapy in … – OncLive

Dr. Skarbnik on Combination Strategies of Immunotherapy in …OncLiveAlan Skarbnik, MD, staff physician, department of Bone Marrow Transplant, Department of Lymphoma, John Theurer Cancer Center, discusses combination strategies with immunotherapy for p… Continue reading

2018-03-02 Michael Zand NEWS

Draper touts new bioprocessing method as ‘next big advance in CAR T-cell treatment’ – BioPharma-Reporter.com


SelectScience

Editorial Article: 7 Steps to Better Gene Editing and CRISPR technology – Special Feature
SelectScience
In this editorial feature, we bring you the latest developments in gene editing and CRISPR technology. 02 Mar 2018. AddThis Sharing Buttons. Share to LinkedIn LinkedInShare to Facebook FacebookShare to Twitter TwitterShare to Email EmailShare to More …
Crispr Therapeutics (CRSP) PT Raised to $51.00 at CitigroupThe Ledger Gazette
Analyst Views On Top Movers In Recent Trade: JRjr33, Inc. (JRJR), CRISPR Therapeutics AG (CRSP)Post Analyst
What Recent Ownership Trends Suggest About CRISPR Therapeutics AG (CRSP)’s Future PerformanceStockNewsGazette
The Lincolnian Online –registrarjournal.com –Kaplan Herald
all 12 news articles »
Continue reading

2018-03-02 Michael Zand NEWS

Synthetic Biology Market Dynamics 2017: Opportunities, Risks and … – Healthcare Journal

Synthetic Biology Market Dynamics 2017: Opportunities, Risks and …Healthcare JournalSynthetic Biology term refers the both the design and construction of biological components and entire novel biological systems that do not exist in a natural world a… Continue reading

2018-03-02 Michael Zand NEWS
  • 1
  • …
  • 455
  • 456
  • 457
  • 458
  • 459
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

BioPharma-Reporter.com

Draper touts new bioprocessing method as ‘next big advance in CAR T-cell treatment’
BioPharma-Reporter.com
Viral vectors, the delivery vehicle of genomic materials into specific cells, can account for as much as 75% of a treatment’s cost, according to the company. “Second, the device removes the expense of additional touch labor and reduces the potential …